Published Nov 16, 2026, 7:05 AM ET · Updated 4 hours ago · 2 sources
Eli Lilly Agrees to Buy Calytrix Bio for Up to $1.5 Billion
bloomberg
·
Original Report
INFERY

Eli Lilly & Co. agreed to buy Calytrix Bio, Inc. in a deal that could be worth up to $1.5 billion in the latest transaction by the acquisitive US drug company.